MMP14, matrix metallopeptidase 14, 4323

N. diseases: 340; N. variants: 7
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.030 Biomarker phenotype BEFREE EphA2 processing by MT1-MMP is associated with malignant transformation in ovarian tumours. 29970559 2018
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.030 Biomarker phenotype BEFREE The most extensively studied MMP14/MT1-MMP is induced in various cancers along malignant transformation via pathways activated by mutations in tumor suppressors or proto-oncogenes and changes in tumor microenvironment including cellular heterogeneity, extracellular matrix composition, tissue oxygenation, and inflammation. 28390905 2017
CUI: C1608408
Disease: Malignant transformation
Malignant transformation
0.030 Biomarker phenotype BEFREE Accordingly, we hypothesized that MT1-MMP is an oncogene that promotes malignant transformation of normal cells rather than just an enzyme that supports growth of preexisting tumors. 17079467 2006